All studies
CompletedInterventional

Allopurinol in Functional Impairment (ALFIE) trial: improving muscle strength

As people grow older, natural muscle loss—known as sarcopenia—can lead to weakness, tiredness, and an increased risk of falls. Exercise helps keep muscles strong, but many older adults have health issues that make regular workouts difficult. Researchers at the University of Dundee wanted to see if an existing, well-known medicine could offer a solution. The ALFIE trial explored whether allopurinol, a drug normally prescribed for gout, can improve muscle performance. Allopurinol is thought to boost blood flow and help muscles use oxygen more effectively, which may stop them from tiring out quickly. In this study, adults aged 65 and older who found it hard to walk briskly took either allopurinol or a dummy pill (placebo) twice a day for 20 weeks. Researchers used simple walking and strength checks alongside routine blood tests to see if the medicine helped leg muscles work better.

At a glance

Status
Completed
Sponsor
University of Dundee (UK)
Enrolment target
124
Start
26 Feb 2015
Estimated completion
22 Feb 2017

What is this study about?

Sarcopenia is the medical term for the natural loss of muscle mass, strength, and function that happens as we age. When leg muscles become weak, simple everyday activities like climbing stairs, getting out of a chair, or carrying shopping can feel exhausting. It can also cause people to walk more slowly and raises the risk of trips and falls, making it harder to live independently.

Staying physically active is one of the best ways to keep muscles strong. However, many older adults live with joint pain, heart trouble, or other long-term conditions that make regular exercise difficult or impossible. Because of this, doctors are searching for safe medicines that can support muscle strength when exercise is not an option.

This trial looked at a medicine called allopurinol. It has been used safely for decades on the NHS to treat gout, a painful joint condition. Scientists discovered that allopurinol can lower harmful substances in muscle tissue called free radicals, improve blood flow, and help muscle fibres absorb oxygen better. Researchers designed this study to find out if taking allopurinol over 20 weeks could make leg muscles work more efficiently in older people with muscle weakness.

Key takeaways

  • The ALFIE study tested whether the gout drug allopurinol can improve muscle strength in older adults.
  • The trial was designed for people aged 65 and older who had trouble walking 400 metres in 6 minutes.
  • Participants took either allopurinol or a dummy pill (placebo) twice a day for 20 weeks.
  • Regular health checks and blood tests were carried out to keep participants safe.
  • The goal was to discover new ways to help older people stay mobile and independent.

Who may be eligible?

This trial was open to men and women aged 65 and over who had noticed significant muscle weakness. To take part, volunteers had to have difficulty walking briskly, meaning they were unable to walk 400 metres (about a quarter of a mile) in a 6-minute walking test.

The study was not suitable for everyone. People could not join if they had severe heart failure, severe chronic lung disease (COPD), or poor blood circulation in the legs (peripheral arterial disease). It was also not open to anyone receiving active cancer treatment, taking high-dose steroid tablets, or dealing with an active flare-up of gout.

Finally, participants needed to be able to follow the trial instructions and carry out basic walking and balance tests safely. Anyone who was already known to be allergic or sensitive to allopurinol was excluded for their own safety.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 65 or older.
  2. I have noticeable leg muscle weakness or struggle with walking long distances.
  3. I am unable to walk 400 metres (around a quarter of a mile) in 6 minutes.
  4. I do not have severe heart failure or severe chronic lung disease (COPD).
  5. I do not currently take allopurinol for active gout flares.
  6. I am not currently taking high-dose steroid tablets.
Answer every question to see your result.

What does participation involve?

Taking part in the trial lasted around 20 weeks. At your first screening visit, the research team carried out a general health check, routine blood tests, and simple movement tests to make sure the trial was safe for you.

If you joined, you were randomly placed into one of two groups by a computer. One group received allopurinol tablets (300 mg twice a day), while the other group received matching dummy tablets (placebo). Neither you nor the study team knew which pill you were taking, ensuring fair results.

Over the 20 weeks, you took your assigned tablets every day at home. You attended two hospital monitoring visits during the study for blood tests and health checks so the doctors could ensure you were tolerating the medicine well. You also repeated physical assessments, like walking tests, to measure how your muscles were responding.

Potential risks and benefits

There was no guarantee of direct personal benefit from joining this trial, as allopurinol is not licensed to treat muscle loss, though researchers hoped it might improve muscle function. The results aim to help doctors develop new treatments for older adults in the future. Allopurinol is generally well-tolerated, but like all medicines, it can cause mild side effects such as an upset stomach or a skin rash. The research team closely monitored participants throughout the trial and provided emergency contact numbers in case anyone felt unwell. Taking part was entirely voluntary, and participants were free to withdraw at any time without their normal NHS care being affected.

Locations (1)

  • University of Dundee
    Approximate
    Dundee, Scotland

Common questions

What is primary sarcopenia?

Primary sarcopenia is the natural loss of muscle strength and muscle bulk that happens simply as a result of getting older, rather than being caused by another specific illness.

Why is a gout medicine being tested for muscle weakness?

Allopurinol reduces stress inside muscle cells, improves blood flow, and helps muscles use oxygen more efficiently, which scientists believe may stop them from tiring out as quickly.

What is a placebo?

A placebo is a dummy pill that looks and tastes identical to the real medicine but contains no active ingredients. It helps researchers prove whether any improvements are truly caused by the drug.

Did participants have to pay for the trial medication?

No. All study medications, appointments, and tests related to clinical trials in the UK are provided free of charge.

Is this study still recruiting?

No, this trial has concluded its recruitment. However, the findings help researchers plan larger studies into muscle health in older age.

How to find out more

Jacob George

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.